Infectious disease · Flowchart
Herpes zoster (shingles)
FreeCause to treatmentHY high-yield
Herpes zoster from VZV reactivation to prevention: a painful dermatomal vesicular rash, zoster ophthalmicus and Ramsay Hunt syndrome, postherpetic neuralgia, antivirals within 72 hours and the recombinant vaccine.
Updated
Whole chart as designed

Read this flowchart as text
The same content as the chart above, step by step. Points marked high-yield are the ones most often tested.
1. Cause
- Reactivation of varicella-zoster virus: Dormant in a dorsal root or cranial nerve ganglion since chickenpox
- Raises the risk: Age over 50, HIV, transplant, cancer, immunosuppressive drugs
2. Pathogenesis
- VZV-specific T-cell immunity falls: The virus travels down the sensory nerve to the skin of one dermatome (high-yield)
3. Signs and symptoms
- Prodrome: Burning, tingling or pain for 2–3 days before the rash
- Painful vesicles in one dermatome: Grouped blisters on a red base, one side, do not cross the midline (thoracic most often); crust in 7–10 days (high-yield)
4. Special forms
- Herpes zoster ophthalmicus: V1; vesicles on the tip of the nose (Hutchinson sign) predict eye involvement (high-yield)
- Ramsay Hunt syndrome: Geniculate ganglion: ear vesicles, facial palsy, hearing loss, vertigo
- Disseminated zoster: Many dermatomes or organs in the immunocompromised
5. Diagnosis
- Clinical diagnosis: From the dermatomal rash
- PCR of vesicle fluid: If atypical; Tzanck smear shows multinucleated giant cells but cannot tell HSV from VZV
6. Complications
- Postherpetic neuralgia: Pain lasting over 3 months; more likely with age (high-yield)
- Eye: Keratitis, uveitis, vision loss
- Other: Bacterial superinfection, encephalitis, myelitis, VZV vasculopathy and stroke
7. Treatment and prevention
- Oral antiviral within 72 hours: Valacyclovir, famciclovir or acyclovir; IV acyclovir if disseminated or immunocompromised (high-yield)
- Treat the pain: Analgesics; for postherpetic neuralgia gabapentin, pregabalin, TCAs, lidocaine patch
- Recombinant zoster vaccine: Two doses for adults 50 and over and immunocompromised adults; cover lesions (contagious until crusted)